Senior IT Engineer I – ERP

Ultragenyx Pharmaceutical, Inc.

Bedford, MA

Apply
JOB DETAILS
JOB TYPE
Full-time, Employee
SKILLS
Accounts Payable, Accounts Receivable, Biotech and Pharmaceutical, ERP (Enterprise Resource Planning), Finance, General Ledger Accounting, Information Technology & Information Systems, Oracle, Oracle Accounts Payable, Oracle ERP, Oracle PL-SQL, Process Costing, Process Engineering, Process Manufacturing, Purchasing/Procurement, Requirements Management, Shipping/Receiving, Supply Chain Management, Unix Shell Programming
LOCATION
Bedford, MA
POSTED
4 days ago
Senior IT Engineer I – ERP (Ultragenyx Pharmaceutical, Inc., Bedford, MA). Requires a bachelor’s or foreign equivalent degree in Information Technology, Computer Information Systems, or related discipline and 8 years of experience in the job offered or 8 years of experience providing techno functional support for process enhancements on the Oracle E-Business Suite R12.2 platforms (EBS) in a Process Manufacturing (OPM) environment. Also required is 8 years of experience: interacting with business and IT functional leads to translate requirements into technical solutions; analyzing, developing, implementing, upgrading, and testing E-Business suite of applications for given requirements; preparing design documents, job aids, and work instruction documents, and conducting demos and trainings related to Oracle E-Business suite of applications; utilizing Oracle E-Business Suite R12, with a primary focus on Procurement and Receiving, Inventory & WMS, MWA, Oracle Processing Modules (Process Engineer, Batch Execution, Process Costing), OM & Shipping, Oracle ERES, AME and Workflow; and utilizing Oracle Advance Supply Chain Planning, Oracle Finance (AP/AR/GL) modules, and iSupplier/iSourcing/iProcurement, PLSQL, and Shell Scripts. We are offering a salary of at least $146,806/year. Apply w/resume to: Jennifer Jigalin, Ultragenyx Pharmaceutical, Inc., 60 Leveroni Court, Novato, CA 94949. No relocation available. No 3rd party responses. EOE.

About the Company

U

Ultragenyx Pharmaceutical, Inc.